{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Carcinoma%2C+Small+Cell+Lung&page=44", "query": { "condition": "Carcinoma, Small Cell Lung", "page": 44 }, "page_size": 10 }, "pagination": { "page": 44, "page_size": 10, "total_count": 4124, "total_pages": 413, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Carcinoma%2C+Small+Cell+Lung&page=45&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Carcinoma%2C+Small+Cell+Lung&page=43&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T10:33:17.513Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00249964", "title": "Combination Paclitaxel, Carboplatin and Temozolomide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Diseases", "Cancer" ], "interventions": [ { "name": "Combination Treatment - Cohort 1", "type": "DRUG" }, { "name": "Combination Treatment - Cohort 2", "type": "DRUG" }, { "name": "Combination Treatment - Cohort 3", "type": "DRUG" }, { "name": "Combination Treatment - Cohort 4", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New Mexico Cancer Research Alliance", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2003-11", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2016-01-20", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00249964" }, { "nct_id": "NCT03829332", "title": "Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-small Cell Lung Cancer" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Lenvatinib", "type": "DRUG" }, { "name": "Placebo for lenvatinib", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 623, "start_date": "2019-03-13", "completion_date": "2024-04-24", "has_results": true, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 18, "location_summary": "Anchorage, Alaska • Chandler, Arizona • Bakersfield, California + 15 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03829332" }, { "nct_id": "NCT03041311", "title": "Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "Trilaciclib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "G1 Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 107, "start_date": "2017-06-29", "completion_date": "2020-10-29", "has_results": true, "last_update_posted_date": "2025-09-25", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 23, "location_summary": "Beverly Hills, California • Fullerton, California • Loma Linda, California + 19 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03041311" }, { "nct_id": "NCT06244771", "title": "A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumors With KRAS G12C Mutations", "Solid Tumor, Adult", "Unresectable Solid Tumor", "Metastatic Solid Tumor", "Non Small Cell Lung Cancer", "Colorectal Cancer", "KRAS G12C", "Pancreatic Cancer" ], "interventions": [ { "name": "FMC-376", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Frontier Medicines Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 403, "start_date": "2024-02-12", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 15, "location_summary": "La Jolla, California • Orange, California • San Francisco, California + 11 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Lake Mary", "state": "Florida" }, { "city": "Dyer", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06244771" }, { "nct_id": "NCT02669914", "title": "MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer", "Nonsmall Cell Lung Cancer", "Breast Cancer", "Cancer of Breast", "Cancer of the Breast", "Gastroesophageal Cancer", "Pancreatic Cancer", "Cancer of the Pancreas", "Colorectal Cancer", "Colorectal Carcinoma", "Renal Cancer", "Kidney Cancer", "Cancer of the Kidney", "Cancer of Kidney", "Ovarian Cancer", "Ovary Cancer", "Cancer of the Ovary", "Cancer of Ovary" ], "interventions": [ { "name": "MEDI4736", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2016-09-12", "completion_date": "2018-01-11", "has_results": true, "last_update_posted_date": "2018-11-06", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02669914" }, { "nct_id": "NCT01025284", "title": "A Study for Participants With Small-Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "LY2523355", "type": "DRUG" }, { "name": "Granulocyte colony-stimulating factor (G-CSF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2009-12", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2019-09-17", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 8, "location_summary": "Torrington, Connecticut • Athens, Georgia • Marietta, Georgia + 5 more", "locations": [ { "city": "Torrington", "state": "Connecticut" }, { "city": "Athens", "state": "Georgia" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Scarborough", "state": "Maine" }, { "city": "Cherry Hill", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01025284" }, { "nct_id": "NCT03217071", "title": "Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "stereotactic radiation therapy (SRT)", "type": "RADIATION" }, { "name": "Surgery (Non-interventional, standard of care)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE" ], "sponsor": "Sue Yom", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2017-10-04", "completion_date": "2022-03-31", "has_results": true, "last_update_posted_date": "2024-10-23", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03217071" }, { "nct_id": "NCT04299048", "title": "Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cachexia", "Non-Small-Cell Lung Cancer", "Pancreatic Cancer", "Colorectal Cancer" ], "interventions": [ { "name": "PF-06946860", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2020-11-17", "completion_date": "2022-03-30", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 10, "location_summary": "Beverly Hills, California • Grand Junction, Colorado • Wheat Ridge, Colorado + 7 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Grand Junction", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Tallahassee", "state": "Florida" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04299048" }, { "nct_id": "NCT01611584", "title": "A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Cancer in Normal and Malignant Tumors" ], "interventions": [ { "name": "ALA-induced Fluorescence", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2010-06", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2014-11-13", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT01611584" }, { "nct_id": "NCT01076504", "title": "A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Extensive-Stage Small Cell Lung Cancer" ], "interventions": [ { "name": "Amrubicin", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SCRI Development Innovations, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2009-12", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2016-05-05", "last_synced_at": "2026-10-19T10:33:17.513Z", "location_count": 20, "location_summary": "Jonesboro, Arkansas • Fort Myers, Florida • Lakeland, Florida + 15 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01076504" } ] }